Health Rising’s 2024 BIG (little) End of the Year Donation Drive

75000
17774
+100%-

Another ME/CFS Moment Occurs

Another ME/CFS “moment” – a sign that things are changing for people with ME/CFS and related diseases – recently occurred. It’s coming right on the heels of our last ME/CFS moment – last month’s announcement of an earpiece specifically designed to assess the time spent upright with people with ME/CFS, long COVID, POTS, etc.

Could the New STAT Earpiece Bring Instant Credibility to ME/CFS, POTS and Long COVID?

This is a kind of a big one – it’s the emergence of Metrodora – a new medical and research center focused entirely on neuroimmune axis disorders such as chronic fatigue syndrome (ME/CFS), fibromyalgia, dysautonomia, postural orthostatic tachycardia syndrome (POTS), and migraine.

Obviously, we need lots of these centers. They would fill a huge unmet need – and serve a huge population. If Metrodora – which aims to bring state-of-the-art research, testing, and treatment (and validation) to these diseases – can pull this off, we should see more Metrodoras in the future.

Metrodora

Metrodora – a 55,000 sq. ft. research and clinical center focused on diseases like ME/CFS, fibromyalgia, POTS, migraine, and others.

The title of an article on Metrodora – “Instacart CEO’s medical institute reimagines neuroimmune diseases” got it right and wrong. Yes, Metrodora is bringing a brand new (and very welcome) approach to these diseases, but you can’t really re-imagine an area, though, that has never been fully “imagined”; i.e. fully explored in the first place.

None of these diseases have gotten the attention they deserve. Despite the fact that they affect tens of millions of people in the U.S. combined, research and clinical centers are few and far between. It’s as if the American medical system simply decided that a huge swath of illnesses were not for it.

These “invisible”, female-dominated diseases, cause massive amounts of fatigue and pain but generally do not cause death (although some hope for it), produce multisystemic symptoms and problems, have few or no accepted treatment options, and get lousy funding. Metrodora co-founder Laura Pace MD, Ph.D. called them “a massive, neglected disease space that disproportionately impacts women”.

All have been kind of haphazardly and unhappily slotted somewhere into the medical firmament and that’s why Metrodora – which was named after the female author of an ancient Greek medical text, “On the Diseases and Cures of Women” – has such promise.

The Buck Stopped Here

It was probably only a matter of time before someone said the buck stops here and did something about it. It stopped with one of the top female entrepreneurs in the country, Instacart’s Fidji Simo, who found herself traveling the long, confusing, and ultimately lonely road through the medical system that so many of us know so well.

The Co-Founder of Metrodora and President of the Metrodora Foundation, Simo is the Chief Executive Officer of Instacart and was previously the Head of Facebook App. She was recognized by Fortune as one of their “40 under 40” annual ranking of the most influential young people in business and was #2 on Fast Company’s 2017 list of Most Creative People in Business.

Proving that illness doesn’t respect wealth, skills, or good fortune, it took her three years of searching before she was finally diagnosed with POTS in 2020 – a condition easily diagnosed with a tilt table test – but which is an utter mystery to most doctors.

A long search for a POTS diagnosis sparked Fidjii Simo's interest in co-creating Metrodora.

A long search for a POTS diagnosis sparked Fidji Simo’s interest in co-creating Metrodora.

Calling her journey a “crazy diagnostic odyssey”, Simo said, “I was diagnosed with one of these conditions three years ago, bouncing from specialist to specialist, with no one really looking at the full picture. Going through the system, I felt like doctors were looking at me like a set of body parts. A lot of these [illnesses] are multisystem conditions, which means you’re falling apart from head to toe.”

Laura Pace, MD, PhD – one of Metrodora’s co-founders – agreed stating that “the current system is set up to care for people that have well-defined diseases with algorithms on how to treat them.” Patients with more complex disorders, she said, “can go from doctor to doctor, collecting diagnoses — all of which are wrong.” (Better diagnostic procedures are going to be a strong focus at Metrodora.)

Simo’s dysautonomia doctor introduced her to Laura Pace, who – also not happy with the state of neuroimmune illness in the medical system – had been considering starting a neuroimmune research center herself. Backed by $35 million in corporate venture funds, she, Laura Pace, and James Hemp PhD cofounded Metrodora.

In a recent YouTube video, Pace came across as a highly informed, precise researcher/doctor who believes medicine has just scratched the surface regarding these diseases. She, for instance, rejects the terms IBS and small intestinal bowel overgrowth (SIBO), believing the conditions are much more complex than those terms describe.

Gut Disruption and Dysfunction in Post Viral Diseases – Laura Pace’s Bracing Talk

A Rheumatoid Arthritis, ME/CFS, and Fibromyalgia Aside

Pace’s breadth of knowledge came across when she described an intriguing autoimmune connection involving rheumatoid arthritis (RA). Despite the fact that RA can be associated with enormous fatigue, and exercise is often problematic, RA clinical trials focus entirely on the joints and never assess the impact of treatments on the fatigue that can affect functionality so much.

Pace believes the fatigue found in RA constitutes the neuroimmune side of it. Her conception of RA – bringing in the side of it which bears similarity to ME/CFS/FM etc – is welcome not just for RA sufferers but potentially for people with other fatigue disorders. (People with RA also have an increased risk of coming down with fibromyalgia.)

One recent study found that RA is an inflammatory “disease characterized by “parasympathetic autonomic dysfunction“. Exercise triggers both an unusual immune reaction and a hyperactive sympathetic nervous system response. (The author of the study said similar findings were showing up in long COVID.) Connections are clearly waiting to be made between other fatiguing diseases like RA and multiple sclerosis and ME/CFS/FM/Long COVID and others.

Is the Exercise Intolerance in Rheumatoid Arthritis and ME/CFS Similar?

PathAI

PathAI is one of the AI firms Metrodora is using to better understand these diseases.

health rising donations

Health Rising's End of the Year Fundraising Drive

If getting the latest news on cutting-edge research and treatments in ME/CFS, fibromyalgia, long COVID, and related diseases supports you, please support Health Rising in it's end of the year fundraising drive. We are entirely community supported.

Paypal, checks, Amazon gift cards, and bitcoin work for us.

Use the widget on the right hand side to donate via Paypal or click here. To find out more, click here. Thanks!


A Hi-Tech Focus

THE GIST

  • Another “ME/CFS moment” – a sign that things are changing for the better for ME/CFS/FM and related diseases – has occurred. It’s coming right on the heels of the last ME/CFS moment – the STAT earpiece that was designed specifically for these diseases.
  • This is a pretty big one – it’s the emergence of Metrodora – a new medical and research center focused entirely on neuroimmune axis disorders such as chronic fatigue syndrome (ME/CFS), fibromyalgia, dysautonomia, postural orthostatic tachycardia syndrome (POTS), and migraine.
  • Metrodora was co-founded by one of the top female entrepreneurs in the country,  Instacart’s Fidji Simo, who found herself traveling the long, confusing, and ultimately lonely road through the medical system that so many of us know so well.
  • If Metrodora – which was named after the female author of an ancient Greek medical text, “On the Diseases and Cures of Women” – can pull this off we should see more of these Centers pop up. One wonders why it wouldn’t be able to given the huge population of mostly women who aren’t finding much help at their doctors.
  • Backed by $35 million in corporate venture funds, the 55,000 sq. ft facility will Metrodora will rely heavily on new tech, including AI-powered biobanking, remote patient monitoring, and collecting electronic health record data via EHR partner Athenahealth.
  • Metrodora for-profit clinical arm plans to accept insurance and it also has a non-profit research arm.
  • Metrodora aims to see 20,000 patients each year and share its datasets and samples with research organizations and digital health companies. Co-founder Pace said, “We’re creating a solution that I, as a practicing physician, always wanted.” Metrodora is located in West Valley City – a suburb of Salt Lake City, Utah.
  • Interested in checking out Metrodora? Call (385) 430-1430
  • Health Rising is not affiliated with Metrodora in any way.

With Simo’s IT background, it’s no surprise that Metrodora will rely heavily on new tech, including AI-powered biobanking, remote patient monitoring, and collecting electronic health record data via EHR partner Athenahealth.

Metrodora is using AI to understand how these complex multi-systemic diseases that so often fall through the cracks (because they are multisystemic) work. That includes working with PathAI, which uses AI solutions to provide diagnostic analyses of patient samples; Fabric Genomics, which will use AI to identify and prioritize new genome variants using its $1K complete whole genome test, NeuraLight to assist with diagnosis and monitoring, and Biofourmis, which uses analytics and wearables to help patients manage chronic conditions.

NeuraLight is one of those kind of head-shaking companies that is using new technology to do wild things. Metrodora will use NeuraLight and its “oculomotor profiles”  – which can be assessed using a smartphone – to diagnose and assess the progression of disorders.

Metrodora has a for-profit clinical arm that plans to accept insurance and see patients with a non-profit research arm.

Metrodora aims to see 20,000 patients each year and share its datasets and samples with partners including research organizations and digital health companies. Metrodora’s emergence is another sign that diseases like ME/CFS, FM, POTS, and others are being taken seriously. May it be successful and may many more Metrodora’s show up.

Co-founder Pace said, “We’re creating a solution that I, as a practicing physician, always wanted.” Metrodora is located in West Valley City – a suburb of Salt Lake City, Utah.

Update

Or maybe it’s not the opportunity she wanted. Just a couple of months after Metrodora opened it announced that Dr. Laura Pace is no longer practicing at Metrodora.  Here’s the communication from mid-September

Metrodora Institute

To our patients,

We are writing to share an important update, on September 13th, Dr. Laura Pace made the difficult decision to step away from her clinical practice at Metrodora Institute. Dr. Pace’s contributions to our medical community have been immeasurable, and her vision for what patient care could be has inspired all of us at Metrodora Institute. Her dedication, expertise, and compassion have touched the lives of countless patients, and we are incredibly grateful.

We also want to take this opportunity to express our heartfelt appreciation for each of you, our patients. Your trust in us, your active participation in your healthcare, and your commitment to your well-being are the pillars upon which our practice is built. You are not just patients; you are our valued partners on this journey towards better health, and for that, we are thankful.

As we move forward, we want to assure you that we are committed to the vision and mission that Dr. Pace set forth with Metrodora Institute. We are dedicated to upholding the standards of excellence in medical care that you have come to expect from us. Your health and well-being remain our top priorities.

To ensure that your healthcare needs continue to be met, we are fortunate to have a dedicated team of healthcare providers who are ready to serve you. Our outstanding physicians include:

  • Dr. Anne Maitland – Allergy/Immunology Specialist Dr. Maitland brings a wealth of knowledge and experience in allergy and immunology, specializing in the diagnosis and treatment of allergies and immune system disorders. She is committed to providing you with expert care and personalized treatment plans.
  • Dr. Joseph Berman – Primary Care Physician Dr. Berman is your trusted partner in maintaining your overall health and well-being. He provides comprehensive primary care services, including preventive care, routine check-ups, and management of chronic conditions, to ensure you receive the best possible care.
  • Dr. Nada Hindiyeh – Neurology/Headache/Migraine Specialist Dr. Hindiyeh specializes in neurology and has a particular focus on the management of headaches and migraines. Her expertise will help address neurological concerns and provide targeted treatments to improve your quality of life.
  • Dr. Erikson Yap – Gastroenterologist: Dr. Yap specializes in gastroenterology and oversees our endoscopy center, ensuring that you receive the highest standard of care for gastrointestinal concerns.

Additionally, we are proud to have a dedicated Neurorehabilitation Team who specialize in treating neuro immune axis disorders, with skilled professionals in:

  • Occupational Therapy: Our occupational therapists focus on helping you regain and maintain your independence in daily life.
  • Physical Therapy: Our physical therapists are dedicated to maintaining your physical function and mobility helping you achieve your goals.
  • Speech Language Pathology: Our speech-language pathologists provide comprehensive care for speech, language, swallowing and cognitive difficulties, tailoring their services to your specific needs.
  • Dietician: Our registered dietitian offers expert guidance on nutrition, helping you make informed dietary choices that promote your overall health.

We understand that you may have questions and concerns during this transition, and we are here to support you every step of the way. If you are awaiting notes and results, a member of our dedicated clinical team will reach out to you through the patient portal as soon as we have received your outstanding results and have finalized care plans. Our team will provide you with the necessary information, recommendations, and guidance based on your results.

For those requiring ongoing care, we will make every effort to ensure a seamless transition. We will either assist you in scheduling an appointment with another specialist within Metrodora Institute or facilitate a referral to an external provider if necessary. Your continuity of care is of utmost importance to us, and we will work diligently to ensure your healthcare needs are met.

Once again, we want to express our deepest gratitude for your trust, support, and partnership. We understand that change can be challenging, but we are confident that together, we will continue to provide you with the exceptional care you deserve.

Thank you for allowing us to be a part of your healthcare journey. We look forward to serving you with the same dedication and compassion that has always defined Metrodora Institute.

-Your Metrodora Team

Interested in checking out Metrodora? Call (385) 430-1430

Health Rising is not affiliated with Metrodora in any way

Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This